Keyphrases
5-hydroxytryptamine
100%
Antidepressants
100%
Vortioxetine
100%
5-HT3 Receptor
100%
Receptor Antagonism
100%
Rapid Recovery
100%
Cell Firing
100%
Fluoxetine
54%
Neuronal Firing
45%
Suppressant
18%
5-HT1A Receptor Agonist
18%
SERT Occupancy
18%
Fast Recovery
9%
Receptor Agonist
9%
Selective Serotonin Reuptake Inhibitors
9%
Therapeutic Effect
9%
Occupancy
9%
Multimodal Antidepressants
9%
5-HT Transporter
9%
5-HT3
9%
5-HT1B Receptor
9%
Partial Agonist
9%
Anesthetized Rats
9%
Fire Behavior
9%
SERT Inhibitor
9%
In Vitro Autoradiography
9%
Brain 5-HT System
9%
5-HT7 Receptor Antagonist
9%
Subchronic Effect
9%
In Vivo Electrophysiological Recording
9%
Lu AA21004
9%
Dorsal Raphe nucleus
9%
Number of Patients
9%
Acute Effects
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Vortioxetine
100%
Serotonin 3 Receptor
100%
Fluoxetine
50%
Receptor Agonist
25%
4 Amino 1 (6 Chloro 2 Pyridyl)piperidine
25%
Flesinoxan
25%
Selective Serotonin Reuptake Inhibitor
8%
Partial Agonist
8%
Therapeutic Effect
8%
Serotonin Transporter
8%
Antidepressant
8%
Serotonin 1B Antagonist
8%
Autoradiography
8%